Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 17;26(3):375.
doi: 10.3892/ol.2023.13959. eCollection 2023 Sep.

Prostate biopsy approach and complication rates

Affiliations

Prostate biopsy approach and complication rates

Kinga Mate et al. Oncol Lett. .

Abstract

Prostate biopsy is the gold standard to confirm prostate cancer. In addition to standard 12-core biopsies, magnetic resonance imaging (MRI)-guided prostate biopsies have recently been introduced to improve the detection of clinically significant prostate cancer. The present study aimed to compare the complications after standard transrectal ultrasound-guided and standard plus targeted (MRI-guided) prostate biopsies, to study the impact of the number of biopsy cores on complication rates, and to compare complication rates after transrectal ultrasound-guided prostate biopsies with those following transperineal prostate biopsies from the literature. A prospective study was performed, which included 135 patients who underwent transrectal ultrasound-guided prostate biopsies between April 1 and June 30, 2022, at the Urology Department of the University Hospital of Pointe à Pitre (Pointe à Pitre, Guadeloupe). A total of 51 patients were excluded because of missing information concerning their post-biopsy surveillance. The median age at the time of biopsy was 69 years, median prostate-specific antigen value was 8.9 ng/ml, median prostate volume was 57.5 ml, and median number of cores was 15. A total of 35 of the 84 included patients (41.7%) had a standard biopsy only and 49 (58.3%) had targeted (MRI-guided) plus standard biopsies. A total of 53 patients (63.1%) experienced early side effects, whereas only 24 patients (28.6%) experienced late side effects. Three patients (3.6%) required hospitalization for post-biopsy complications. Early side effects, especially hematuria and hematospermia, occurred significantly more frequently in the targeted plus standard group, with more cores taken, with no significant difference concerning late side effects or infectious complications between the standard and standard plus targeted groups. The admission rate for sepsis after transperineal biopsy has been reported to vary between 0 and 1%, whereas the present study had an admission rate of 2.29% using the transrectal approach. Further studies are required to analyze the complications requiring hospitalization after transrectal and transperineal biopsies.

Keywords: MRI-guided; complications; hematospermia; hematuria; infections; prostate biopsy; rectal bleeding; sepsis; transperineal; transrectal; urinary retention.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Overduin CG, Fütterer JJ, Barentsz JO, Futterer JJ, Barentsz JO. MRI-guided biopsy for prostate cancer detection: A systematic review of current clinical results. Curr Urol Rep. 2013;14:209–213. doi: 10.1007/s11934-013-0323-z. - DOI - PubMed
    1. Zattoni F, Marra G, Kasivisvanathan V, Grummet J, Nandurkar R, Ploussard G, Olivier J, Chiu PK, Valerio M, Gontero P, et al. The detection of prostate cancer with magnetic resonance imaging-targeted prostate biopsies is superior with the transperineal vs the transrectal approach. A European association of urology-young academic urologists prostate cancer working group multi-institutional study. J Urol. 2022;208:830–837. doi: 10.1097/JU.0000000000002802. - DOI - PubMed
    1. Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, Weidner W, Loeb S. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71:353–365. doi: 10.1016/j.eururo.2016.08.004. - DOI - PubMed
    1. Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, Rosario DJ, Scattoni V, Lotan Y. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64:876–892. doi: 10.1016/j.eururo.2013.05.049. - DOI - PubMed
    1. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: A study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004;94:1014–1020. doi: 10.1111/j.1464-410X.2004.05096.x. - DOI - PubMed

LinkOut - more resources